MIHPC's report highlights major disparities in drug prices across Michigan hospitals, showcasing the urgent need for transparency and accountability.

The Michigan Health Purchasers Coalition (MIHPC) has released three research reports highlighting perceived disparities in ...

Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis.

Bengaluru: Biocon Biologics Limited has announced that the Government of Malaysia has agreed to extend the current contract ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced today that the U.S. Food and Drug Administration (FDA) designated Otulfi® (ustekinumab-aauz) as an interchangeable ...

and Stimufend® (pegfilgrastim-fpgk). Fresenius Kabi’s growing pipeline of autoimmune and oncology biosimilars has several molecules in early and late-stage development. Otulfi (ustekinumab-aauz ...

Under the Healthcare Common Procedure Coding System (HCPCS), the Q-code Q9999 is for “Injection ... and Stimufend® (pegfilgrastim-fpgk). Fresenius’s growing pipeline of autoimmune and ...

Later this year, we have several key complex product launches, including Triforte ophthalmic suspension and Risperidone injection ... BLA filings for pegfilgrastim, OBI and autoinjector, is ...

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q1 2025 Earnings Call Transcript May 2, 2025 Operator: Good morning and welcome to the Amneal Pharmaceuticals First Quarter 2025 Earnings Call. I’d now ...

Last month, Sandoz revealed that the FDA had rejected its biosimilar of Amgen's Neulasta (pegfilgrastim ... Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum ...